Age bias in clinical trials in sepsis: How relevant are guidelines to older people?

Journal of Critical Care

Volumn 24, Issue 4, 2009, Pages 609-613

  Rajapakse, Senaka ^a   Rajapakse, Anoja ^b  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b Sherwood Forest NHS Trust ^*  (United Kingdom)

Author keywords

Clinical trials; Elderly; Sepsis

Indexed keywords

ACTIVATED PROTEIN C; CORTICOSTEROID;

ADULT RESPIRATORY DISTRESS SYNDROME; AGE DISTRIBUTION; ARTIFICIAL VENTILATION; CLINICAL RESEARCH; CLINICAL TRIAL; COMORBIDITY; CONTINUOUS RENAL REPLACEMENT THERAPY; DRUG EFFICACY; GLYCEMIC CONTROL; HUMAN; LOW DRUG DOSE; MORTALITY; PATIENT SAFETY; PRACTICE GUIDELINE; RESUSCITATION; REVIEW; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; TREATMENT OUTCOME;

AGE DISTRIBUTION; BLOOD GLUCOSE; CLINICAL TRIALS AS TOPIC; GLUCOCORTICOIDS; HUMANS; PRACTICE GUIDELINES AS TOPIC; PROTEIN C; RECOMBINANT PROTEINS; RENAL REPLACEMENT THERAPY; RESEARCH DESIGN; RESPIRATION, ARTIFICIAL; RESUSCITATION; SEPSIS;

EID: 70449530849     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2008.11.009     Document Type: Review

References (47)

1. Martin G.S., Mannino D.M., Eaton S., and Marc Moss M.D. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (2003) 1546-1554
2. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., and Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 (2001) 1303-1310
3. Martin G.S., Mannino D.M., and Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med 34 (2006) 15-21
4. Bugeja G., Kumar A., and Banerjee A.K. Exclusion of elderly people from clinical research: a descriptive study of published reports. Br Med J 315 (1997) 1059
5. Hamel M.B., Teno J.M., Goldman L., et al. Patient age and decisions to withhold life-sustaining treatments from seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Ann Intern Med 130 (1999) 116-125
6. Chelluri L., Pinsky M.R., Donahoe M.P., et al. Long-term outcome of critically ill elderly patients requiring intensive care. JAMA 269 (1993) 3119-3123
7. McMurdo M.E.T., Witham M.D., and Gillespie N.D. Including older people in clinical research. Br Med J 331 (2005) 1036-1037
8. Dellinger P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34 (2008) 17-60
9. Rivers E., Nguyen B., Havstad S., et al., Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 (2001) 1368-1377
10. Gattinoni L., Brazzi L., Pelosi P., et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 333 (1995) 1025-1032
11. Finfer S., Bellomo R., Boyce N., et al., SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350 (2004) 2247-2256
12. Perez A. Bench-to-bedside review: the initial hemodynamic resuscitation of the septic patient according to Surviving Sepsis Campaign guidelines-does one size fit all?. Critical Care 12 (2008) 223 10.1186/cc6979
13. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002) 862-871
14. Briegel J., Forst H., Haller M., et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27 (1999) 723-732
15. Bollaert P.E., Charpentier C., Levy B., et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26 (1998) 645-650
16. Sprung C.L., Annane D., Keh D., et al., CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med 358 (2008) 111-124
17. Yildiz O., Doganay M., Aygen B., et al. Physiologic-dose steroid therapy in sepsis. Crit Care 6 (2002) 251-259
18. Keh D., Boehnke T., Weber-Cartens S., et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 167 (2003) 512-520
19. Oppert M., Schindler R., Husung C., et al. Low dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 33 (2005) 2457-2464
20. Confalonieri M., Urbino R., Potena A., et al. Hydrocortisone infusion for severe community-acquired pneumonia. A preliminary randomized study. Am J Respir Crit Care Med 171 (2005) 242-248
21. Bernard G.R., Vincent J.L., Laterre P.F., et al., Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein c for severe sepsis. N Engl J Med 344 (2001) 699-709
22. Abraham E., Laterre P.F., Garg R., et al., Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 353 (2005) 1332-1341
23. Ely E.W., Laterre P.F., Angus D.C., et al. Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med 31 (2003) 12-19
24. Behrendt C.E. Acute respiratory failure in the United States: incidence and 31-day survival. Chest 118 (2000) 1100-1105
25. Ely E.W., Gregory W., Evans M.A., et al. Mechanical ventilation in a cohort of elderly patients admitted to an intensive care unit. Ann Intern Med. 131 (1999) 96-104
26. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342 (2000) 1301-1308
27. Amato M.B., Barbas C.S., Medeiros D.M., et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338 (1998) 347-354
28. Brochard L., Roudot-Thoraval F., Roupie E., et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. Am J Respir Crit Care Med 158 (1998) 1831-1838
29. Brower R.G., Shanholtz C.B., Fessler H.E., et al. Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 27 (1999) 1492-1498
30. Stewart T.E., Meade M.O., Cook D.J., et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. N Engl J Med 338 (1998) 355-361
31. Ely E.W., Wheeler A.P., Thompson B.T., Ancuckiewicz M., et al. Recovery rate and prognosis in older persons who develop acute lung injury and the acute respiratory distress syndrome. Ann Intern Med 136 (2002) 25-36
32. ARDS Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354 (2006) 2564-2575
33. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345 (2001) 1359-1367
34. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461
35. Meneilly G.S., Cheung E., and Tuokko H. Altered responses to hypoglycaemia of healthy elderly people. J Clin Endocrinol Metab 78 (1994) 1341-1348
36. Weiner R.S., Weiner D.C., and Larson R.J. Benefits and risks of tight glycaemic control in critically ill adults. JAMA 300 (2008) 933-944
37. Ronco C., Bellomo R., Homel P., et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356 (2000) 26-30
38. Mehta R.L., McDonald B., Gabbai F.B., et al. Collaborative group for treatment of ARF in the ICU. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 60 (2001) 1154-1163
39. Uehlinger D.E., Jakob S.M., Ferrari P., et al. Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 20 (2005) 1630-1637
40. Augustine J.J., Sandy D., Seifert T.H., et al. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 44 (2005) 1000-1007
41. Vinsonneau C., Camus C., Combes A., et al. Hemodiafe Study Group. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 368 (2006) 379-385
42. John S., Griesbach D., Baumgärtel M., et al. Effects of continuous haemofiltration vs intermittent heamodialysis on systemic heamodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. Nephrol Dial Transplant 16 (2001) 320-327
43. Schiffl H., Lang S.M., Fischer R., et al. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346 (2002) 305-310
44. Bouman C.S., Oudemans-Van Straaten H.M., Tijssen J.G., et al. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 30 (2002) 2205-2211
45. McLean A.J., and Le Couteur D.G. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 56 (2004) 163-184
46. Hurwitz N., and Wade O.L. Intensive hospital monitoring of adverse reactions to drugs. Br Med J 1 (1969) 513-536
47. Lamy P.P. Comparative pharmacokinetic changes and drug therapy in an older population. J Am Geriatr Soc 30 (1982) S11-S19